The Secretary’s announcement follows two rounds of changes to the Part 2 regulations that sought to improve the sharing of SUD treatment information among healthcare providers. Treatment advocates and policy makers have maintained that, among other things, further harmonization of the HIPAA and Part 2 requirements is necessary to improve the sharing of patient treatment information. The final report issued by the President’s Commission on Combating Drug Addiction and the Opioid Crisis in November of 2017 recommended similar regulatory changes and also noted that changes could be implemented through bipartisan legislation introduced in Congress. In June of this year, the House passed bipartisan legislation (by a vote of 357 to 57) that would, among other changes, allow disclosure of SUD treatment records without a patient’s written consent to covered entities for purposes of treatment, payment, and healthcare operations in accordance with HIPAA privacy regulations. While similar, albeit narrower, legislation has been introduced in the Senate, it is unclear whether such changes will be included in final legislation.
The forthcoming RFI presents an opportunity for stakeholders to engage with HHS on health privacy issues, and to seek reforms designed to account for recent shifts in the industry as well as the potential value of enhanced data sharing with appropriate safeguards.
Sidley Austin LLP provides this information as a service to clients and other friends for educational purposes only. It should not be construed or relied on as legal advice or to create a lawyer-client relationship.
Attorney Advertising - For purposes of compliance with New York State Bar rules, our headquarters are Sidley Austin LLP, 787 Seventh Avenue, New York, NY 10019, 212.839.5300; One South Dearborn, Chicago, IL 60603, 312.853.7000; and 1501 K Street, N.W., Washington, D.C. 20005, 202.736.8000.